Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « MedMesh.i » - entrée « Janus Kinase Inhibitors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Ivermectin < Janus Kinase Inhibitors < Janus Kinases  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000508 (2021) Dingzhong Li ; Jianbing Hu ; Dian Li ; Weijun Yang ; Shuang-Feng Yin ; Renhua QiuReviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19.
000686 (2020) Hilary Miller-Handley ; Keith Luckett ; Amit GovilTreatment Options for Coronavirus Disease 2019 in Patients With Reduced or Absent Kidney Function.
000871 (2021) Kieran Murray ; Sean Quinn ; Matthew Turk ; Anna O'Rourke ; Eamonn Molloy ; Lorraine O'Neill ; Ann Barbara Mongey ; Ursula Fearon ; Douglas J. VealeCOVID-19 and rheumatic musculoskeletal disease patients: infection rates, attitudes and medication adherence in an Irish population.
000A91 (2021) Jose Luis Rodriguez-Garcia ; Gines Sanchez-Nievas ; Juan Arevalo-Serrano ; Cristina Garcia-Gomez ; Jose Maria Jimenez-Vizuete ; Elisa Martinez-AlfaroBaricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: an observational cohort study.
000C59 (2020) Daniel R. Burrage ; Soraya Koushesh ; Nidhi SofatImmunomodulatory Drugs in the Management of SARS-CoV-2.
000F67 (2021) Kevin L. Winthrop ; Amanda E. Brunton ; Susan Beekmann ; Philip Polgreen ; John Baddley ; Kenneth G. Saag ; Cassandra Calabrese ; Leonard Calabrese ; Philip C. Robinson ; Zachary S. Wallace ; Jeffrey R. CurtisSARS CoV-2 infection among patients using immunomodulatory therapies.
001004 (2021) Michael Putman ; Yu Pei Eugenia Chock ; Herman Tam ; Alfred H J. Kim ; Sebastian E. Sattui ; Francis Berenbaum ; Maria I. Danila ; Peter Korsten ; Catalina Sanchez-Alvarez ; Jeffrey A. Sparks ; Laura C. Coates ; Candace Palmerlee ; Andrea Peirce ; Arundathi Jayatilleke ; Sindhu R. Johnson ; Adam Kilian ; Jean Liew ; Larry J. Prokop ; M Hassan Murad ; Rebecca Grainger ; Zachary S. Wallace ; Alí Duarte-GarcíaAntirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.
001166 (2020) Serena Colafrancesco ; Rossana Scrivo ; Cristiana Barbati ; Fabrizio Conti ; Roberta PrioriTargeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.
001172 (2020) Efstathios Kastritis ; George D. Kitas ; Dimitrios Vassilopoulos ; Georgios Giannopoulos ; Meletios A. Dimopoulos ; Petros P. SfikakisSystemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes.
001280 (2020) Giulia Iannaccone ; Roberto Scacciavillani ; Marco Giuseppe Del Buono ; Massimiliano Camilli ; Claudio Ronco ; Carl J. Lavie ; Antonio Abbate ; Filippo Crea ; Massimo Massetti ; Nadia AspromonteWeathering the Cytokine Storm in COVID-19: Therapeutic Implications.
001350 (2020) Saleh A. Alqahtani ; Abdulrahman A. Aljumah ; Almoutaz Hashim ; Thamer H. Alenazi ; Mohammed Aljawad ; Waleed K. Al Hamoudi ; Mohammed Y. AlghamdiPrinciples of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation.
001478 (2020) Carlos Sanchez-Piedra ; Cesar Diaz-Torne ; Javier Manero ; José M. Pego-Reigosa ; Í Igo Rúa-Figueroa ; Miguel A. Gonzalez-Gay ; Juan Gomez-Reino ; Jose M. Alvaro-GraciaClinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
001552 (2020) Milena Gianfrancesco ; Kimme L. Hyrich ; Sarah Al-Adely ; Loreto Carmona ; Maria I. Danila ; Laure Gossec ; Zara Izadi ; Lindsay Jacobsohn ; Patricia Katz ; Saskia Lawson-Tovey ; Elsa F. Mateus ; Stephanie Rush ; Gabriela Schmajuk ; Julia Simard ; Anja Strangfeld ; Laura Trupin ; Katherine D. Wysham ; Suleman Bhana ; Wendy Costello ; Rebecca Grainger ; Jonathan S. Hausmann ; Jean W. Liew ; Emily Sirotich ; Paul Sufka ; Zachary S. Wallace ; Jinoos Yazdany ; Pedro M. Machado ; Philip C. RobinsonCharacteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
001841 (2020) Ted R. Mikuls ; Sindhu R. Johnson ; Liana Fraenkel ; Reuben J. Arasaratnam ; Lindsey R. Baden ; Bonnie L. Bermas ; Winn Chatham ; Stanley Cohen ; Karen Costenbader ; Ellen M. Gravallese ; Andre C. Kalil ; Michael E. Weinblatt ; Kevin Winthrop ; Amy S. Mudano ; Amy Turner ; Kenneth G. SaagAmerican College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.
001882 (2020) Jiancheng Zhang ; Bing Xie ; Kenji HashimotoCurrent status of potential therapeutic candidates for the COVID-19 crisis.
001914 (2021) Ennio Giulio Favalli ; Francesca Ingegnoli ; Rolando Cimaz ; Roberto CaporaliWhat is the true incidence of COVID-19 in patients with rheumatic diseases?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i -k "Janus Kinase Inhibitors" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/MedMesh.i  \
                -Sk "Janus Kinase Inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Janus Kinase Inhibitors
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021